青光眼、黄斑及后极部变性、糖尿病眼部并发症对视力丧失的协同效应
该全国性纵向队列研究利用韩国国民健康保险系统2004至2019年数据,纳入约50万参与者、随访7495390人年,发现青光眼、黄斑及后极部变性、糖尿病眼部并发症均与严重视力障碍风险升高相关,且多种年龄相关眼病共存时风险进一步升高。
要点
- 青光眼、黄斑及后极部变性、糖尿病眼部并发症患者发生严重视力障碍的风险均高于无这些疾病者。
- 合并两种或以上年龄相关眼病时严重视力障碍风险进一步升高。
- 研究结果强调需要整合眼保健,包括预防发生额外的年龄相关眼病。
核心结论
- 多种年龄相关眼病共存会显著升高严重视力障碍风险。
- 研究结果强调需要整合眼保健,包括预防发生额外的年龄相关眼病。
研究设计与样本
- 全国性纵向队列研究,使用韩国国民健康保险系统(KNHIS)国民健康筛查队列2004至2019年数据。
- 纳入约50万名参与者,随访7495390人年。
- 新发年龄相关眼病通过诊断代码联合药物处方识别,严重视力障碍通过KNHIS健康检查记录和国家残疾登记识别。
- 估计调整人口学、行为及合并症后的调整风险比(aHR)及95%CI。
主要发现
- 7296名(1.45%)参与者发生青光眼,1051名(0.21%)发生黄斑及后极部变性,3062名(0.61%)发生糖尿病眼部并发症。
- 与无年龄相关眼病者相比,严重视力障碍的aHR:青光眼为4.78(95%CI 4.00至5.72),黄斑及后极部变性为8.27(95%CI 5.95至11.51),糖尿病眼部并发症为3.23(95%CI 2.38至4.37)。
- 595名(0.12%)参与者发生两种或以上年龄相关眼病。
- 患一种年龄相关眼病者严重视力障碍风险aHR为4.96(95%CI 4.33至5.68),增加第二种年龄相关眼病后aHR为9.54(95%CI 6.37至14.30),增加第三种年龄相关眼病后aHR为12.59(95%CI 2.32至68.44)。
关键数值与推荐
- 青光眼患者严重视力障碍aHR为4.78(95%CI 4.00至5.72)。
- 黄斑及后极部变性患者严重视力障碍aHR为8.27(95%CI 5.95至11.51)。
- 糖尿病眼部并发症患者严重视力障碍aHR为3.23(95%CI 2.38至4.37)。
- 患一种年龄相关眼病者严重视力障碍aHR为4.96(95%CI 4.33至5.68),患两种者为9.54(95%CI 6.37至14.30),患三种者为12.59(95%CI 2.32至68.44)。
临床怎么用
- 原文结论强调需要整合眼保健,包括预防发生额外的年龄相关眼病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Major age-related ocular diseases (ARODs)-glaucoma, degeneration of macula and posterior pole (DMPP) and diabetes mellitus with ophthalmic complications (DOC)-often coexist in ageing populations, but their combined impact on severe visual impairment (VI) remains unclear. This study aimed to determine the coincidence rate of ARODs and evaluate the association between concomitant ARODs and the risk of developing severe VI. METHODS: This nationwide, longitudinal cohort study used data from the Korea National Health Insurance System (KNHIS) National Health Screening Cohort from 2004 to 2019. Incident ARODs were identified by diagnostic codes combined with medication prescriptions. Severe VI was identified through KNHIS health check-up records and the National Disability Registration. Adjusted HRs (aHRs) and 95% CIs were estimated, adjusting for demographic, behavioural and comorbidities. RESULTS: Among 0.5 million participants followed over 7 495 390 person-years, 7296 (1.45%) developed glaucoma, 1051 (0.21%) DMPP and 3062 (0.61%) DOC. Compared with those without AROD, the aHRs for severe VI were 4.78 (95% CI 4.00 to 5.72) for glaucoma, 8.27 (95% CI 5.95 to 11.51) for DMPP and 3.23 (95% CI 2.38 to 4.37) for DOC. A total of 595 individuals (0.12%) developed two or more ARODs. For patients with one AROD, the risk of severe VI (aHR 4.96; 95% CI 4.33 to 5.68) increased 1.93-fold with a second AROD (aHR 9.54; 95% CI 6.37 to 14.30) and 2.54-fold with a third AROD (aHR 12.59; 95% CI 2.32 to 68.44). CONCLUSION: The presence of multiple ARODs significantly elevates the risk of severe VI. These findings emphasise the need for integrated eye care, including prevention of developing additional ARODs.
引用
- Choe S, Xi C, Park DY, et al. Synergistic effects of glaucoma, degeneration of macula and posterior pole, and diabetic ophthalmic complications on vision loss. Br J Ophthalmol. 2026. PMID: 41249002. doi:10.1136/bjo-2025-327643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。